LI-COR Biotech: Odyssey M Chemi/Fluor Imaging Bundle Standard

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

ASA OFFICE OF THE ASSISTANT SECRETARY FOR ADMINISTRATION

Contract Value

Not provided

Codes & Classification
Solicitation Number

75N91026Q00014

NAICS

334516 - Analytical Laboratory Instrument Manufacturing

Classification Code

6640

Additional Details
Set Aside

None

Place of Performance

Bethesda, Maryland, UNITED STATES

SourceSAM
The Department of Health and Human Services, through the Office of the Assistant Secretary for Administration (ASA), has issued a Combined Synopsis/Solicitation for the procurement of the LI-COR Biotech Odyssey M Chemi/Fluor Imaging Bundle Standard. This opportunity, identified under procurement number 75N91026Q00014, is intended to support the National Institutes of Health (NIH), specifically the National Cancer Institute’s Center for Cancer Research and its Laboratory of Human Carcinogenesis, located in Bethesda, Maryland. The primary objective of this procurement is to acquire a state-of-the-art imaging system to replace the laboratory’s outdated and failing protein imager. The new Odyssey M system is critical for advancing ongoing and future intramural research projects and initiatives. Its versatile capabilities are designed to streamline workflows and will be utilized across multiple labs and divisions within the organization. Key requirements for the imaging system include robust support for a wide range of applications essential to cancer research. These applications encompass fluorescent and colorimetric Western blots, immunocytochemistry (including both In-Cell and On-Cell Western assays), Enzyme-Linked Immunosorbent Assays (ELISA), protein and nucleic acid arrays, high-resolution fluorescent and RGB tissue section analysis, fluorescent and colorimetric protein gel detection, nucleic acid detection, and non-isotopic Electrophoretic Mobility Shift Assays. The selected system must deliver high performance and reliability to ensure the continuity and advancement of critical research activities. The procurement is classified under NAICS code 334516 (Analytical Laboratory Instrument Manufacturing), with a corresponding Product Service Code of 6640. The place of performance is Bethesda, Maryland, United States. The solicitation is managed by the ASA Office of the Assistant Secretary for Administration, a federal entity within the Department of Health and Human Services. Interested parties may direct inquiries to the primary contact, Shayna Simpson ([email protected]), or the secondary contact, Rashiid Cummins ([email protected]). The notice was posted on May 6, 2026, and remains active, with responses due by September 6, 2026. Additional information, including attachments and Q&A updates, is available through the official SAM.gov opportunity listing (Opportunity ID: 886c86d3bfde4ad18d943121e83f5ea5). Contractors considering this opportunity should ensure their solutions align with the specified technical requirements and are capable of supporting the diverse and advanced imaging needs of a leading biomedical research laboratory. The procurement process and requirements are expected to remain consistent throughout the contract lifecycle.
Documents6